Saxagliptin Hydrochloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Saxagliptin Hydrochloride
Europe

Axplora- The partner of choice for complex APIs.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Saxagliptin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 12 USDMF, 8 EU WC, 5 NDC API, 5 Listed Suppliers, $ API Reference Price

16 API Suppliers
12 USDMF
8 EU WC
5 NDC API
5 Listed Suppliers
$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers, 30 FDA Orange Book, 2 Europe, 9 Canada

41 FDF Dossiers
30 FDA Orange Book
2 Europe
9 Canada

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 5 Corel Pharma Chem, 6 DFE Pharma, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 26 Kerry, 1 Kima Chemical, 13 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 1 The Dow Chemical Company, 3 Vasa Pharmachem

1 Rochem International Inc
1 SPI Pharma
5 DKSH
3 Faran Shimi Pharmaceutical
4 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Aeon Procare
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
1 Clariant
5 Corel Pharma Chem
6 DFE Pharma
7 Gangwal Chemicals
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
26 Kerry
1 Kima Chemical
13 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
1 The Dow Chemical Company
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 23 Coating Systems & Additives, 17 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 14 Direct Compression, 12 Lubricants & Glidants, 11 Granulation, 8 Controlled & Modified Release, 8 Co-Processed Excipients, 7 Rheology Modifiers, 6 Film Formers & Plasticizers, 3 Taste Masking, 3 Solubilizers, 3 Topical, 3 Emulsifying Agents, 3 Parenteral, 2 API Stability Enhancers, 2 Coloring Agents, 2 Chewable & Orodispersible Aids, 1 Surfactant & Foaming Agents

45 Fillers, Diluents & Binders
23 Coating Systems & Additives
17 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
14 Direct Compression
12 Lubricants & Glidants
11 Granulation
8 Controlled & Modified Release
8 Co-Processed Excipients
7 Rheology Modifiers
6 Film Formers & Plasticizers
3 Taste Masking
3 Solubilizers
3 Topical
3 Emulsifying Agents
3 Parenteral
2 API Stability Enhancers
2 Coloring Agents
2 Chewable & Orodispersible Aids
1 Surfactant & Foaming Agents

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Annual Reports

1 US Medicaid Prescriptions
1 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

82 US Patents, 4 Health Canada Patents

82 US Patents
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 13,363 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2AstraZeneca AB

filter Active Ingredients Reset all filters

2 All

01 2saxagliptinhydroklorid

filter Dosage Form Reset all filters

2 All

01 2FILMDRAGERAD TABLETT

filter Country Reset all filters

2 All

01 2Sweden

filter Brand Name Reset all filters

2 All

01 2Onglyza

List of Suppliers

Product Main Page

01

AstraZeneca AB

NextGen Biomed

Not Confirmed

AstraZeneca AB

NextGen Biomed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

saxagliptinhydroklorid

Brand Name : Onglyza

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AstraZeneca AB

NextGen Biomed

Not Confirmed

AstraZeneca AB

NextGen Biomed

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

saxagliptinhydroklorid

Brand Name : Onglyza

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 2,5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!